AT
The startup develops drugs that modulate the immune system by targeting the stimulator of interferon genes (STING) pathway, which plays a crucial role in the body's response to cancer and serious diseases. This approach enhances the immune response, potentially improving treatment outcomes for patients with cancer.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops drugs that modulate the immune system by targeting the stimulator of interferon genes (STING) pathway, which plays a crucial role in the body's response to cancer and serious diseases. This approach enhances the immune response, potentially improving treatment outcomes for patients with cancer.